- Home
- LNTH vs LLYVK Comparison
LNTH vs LLYVK Comparison
Compare LNTH & LLYVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- LLYVK
- Stock Information
- Founded
- LNTH 1956
- LLYVK 1991
- Country
- LNTH United States
- LLYVK United States
- Employees
- LNTH N/A
- LLYVK N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LLYVK Broadcasting
- Sector
- LNTH Health Care
- LLYVK Industrials
- Exchange
- LNTH Nasdaq
- LLYVK Nasdaq
- Market Cap
- LNTH 6.3B
- LLYVK 6.3B
- IPO Year
- LNTH 2015
- LLYVK N/A
- Fundamental
- Price
- LNTH $89.29
- LLYVK $69.00
- Analyst Decision
- LNTH Strong Buy
- LLYVK
- Analyst Count
- LNTH 6
- LLYVK 0
- Target Price
- LNTH $132.67
- LLYVK N/A
- AVG Volume (30 Days)
- LNTH 1.0M
- LLYVK 359.3K
- Earning Date
- LNTH 11-06-2024
- LLYVK 01-01-0001
- Dividend Yield
- LNTH N/A
- LLYVK N/A
- EPS Growth
- LNTH 304.57
- LLYVK N/A
- EPS
- LNTH 6.02
- LLYVK N/A
- Revenue
- LNTH $1,496,799,000.00
- LLYVK N/A
- Revenue This Year
- LNTH $19.64
- LLYVK N/A
- Revenue Next Year
- LNTH $4.38
- LLYVK $10.07
- P/E Ratio
- LNTH $14.83
- LLYVK N/A
- Revenue Growth
- LNTH 24.15
- LLYVK N/A
- 52 Week Low
- LNTH $50.20
- LLYVK $33.50
- 52 Week High
- LNTH $126.89
- LLYVK $73.89
- Technical
- Relative Strength Index (RSI)
- LNTH 44.02
- LLYVK 50.93
- Support Level
- LNTH $91.20
- LLYVK $67.37
- Resistance Level
- LNTH $96.46
- LLYVK $72.28
- Average True Range (ATR)
- LNTH 2.89
- LLYVK 1.84
- MACD
- LNTH 0.54
- LLYVK -1.02
- Stochastic Oscillator
- LNTH 26.33
- LLYVK 25.89
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About LLYVK Liberty Media Corporation Series C Liberty Live
Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's strategy for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.